This open-label, multi-clinic study in 12 patients with digestive disorders demonstrated that consuming 2 servings daily of an innovative structured nutrition therapy for 6 weeks:
- Reduced GI symptoms and improved overall GI quality of life
- Increased production of SCFA, including butyrate
- Increased levels of Bifidobacterium spp.
- Reduced potential harmful intestinal microbiota
Despite the limited sample size in this preliminary study, this targeted nutrition therapy approach offers promise as a novel nutritional therapy for patients with compromised gut function.